Sveriges mest populära poddar

ERJ Podcast May 2025: Efficacy and safety of the activin signalling inhibitor sotatercept

15 min•29 maj 2025

As part of the May issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Associate Editor Marius Hoeper about the efficacy and safety of the activin signalling inhibitor sotatercept in a pooled analysis of PULSAR and STELLAR studies.

Fler avsnitt av ERS Publications Podcasts

ERJ Podcast August 2026: Fentanyl or morphine for persistent dyspnoea in COPD

28 aug.•10 min

ERJ Podcast July 2026: Nerandomilast in progressive pulmonary fibrosis

12 aug.•11 min

ERS Monograph: Thoracic Ultrasound

10 aug.•16 min

ERJ Podcast June 2026: The ageing lung

16 juli•14 min

ERJ Podcast May 2026: Mucus plugs in asthma and COPD

21 maj•17 min

ERS Monograph: Bronchiectasis

7 maj•19 min

ERJ Podcast April 2026: Use of spirometry to define airflow obstruction and diagnose COPD

1 maj•14 min

ERJ Podcast March 2026: Mortality in severe asthma

30 mars•12 min

ERJ Podcast February 2026: Addressing the global challenges of COPD and asthma

19 feb.•16 min

ERS Monograph: Chronic Cough

13 feb.•27 min

ERS Publications Podcasts med ERS Publications Podcasts finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.